293 related articles for article (PubMed ID: 24047859)
1. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
[TBL] [Abstract][Full Text] [Related]
2. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
3. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
[No Abstract] [Full Text] [Related]
4. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
5. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
[TBL] [Abstract][Full Text] [Related]
6. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
[TBL] [Abstract][Full Text] [Related]
7. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients.
Amre DK; Lu SE; Costea F; Seidman EG
Am J Gastroenterol; 2006 Mar; 101(3):645-52. PubMed ID: 16464223
[TBL] [Abstract][Full Text] [Related]
8. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.
Forcione DG; Rosen MJ; Kisiel JB; Sands BE
Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177
[TBL] [Abstract][Full Text] [Related]
9. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease.
Esters N; Vermeire S; Joossens S; Noman M; Louis E; Belaiche J; De Vos M; Van Gossum A; Pescatore P; Fiasse R; Pelckmans P; Reynaert H; Poulain D; Bossuyt X; Rutgeerts P;
Am J Gastroenterol; 2002 Jun; 97(6):1458-62. PubMed ID: 12094865
[TBL] [Abstract][Full Text] [Related]
10. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
[TBL] [Abstract][Full Text] [Related]
12. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
13. Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1.
Yacyshyn BR; Schievella A; Sewell KL; Tami JA
Clin Exp Immunol; 2005 Jul; 141(1):141-7. PubMed ID: 15958080
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
15. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease.
Israeli E; Grotto I; Gilburd B; Balicer RD; Goldin E; Wiik A; Shoenfeld Y
Gut; 2005 Sep; 54(9):1232-6. PubMed ID: 16099791
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of serological markers in inflammatory bowel disease.
Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies and anthropometric data at diagnosis in pediatric Crohn's disease.
Trauernicht AK; Steiner SJ
Dig Dis Sci; 2012 Apr; 57(4):1020-5. PubMed ID: 22075854
[TBL] [Abstract][Full Text] [Related]
18. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
[TBL] [Abstract][Full Text] [Related]
20. Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.
Bertin D; Grimaud JC; Lesavre N; Benelmouloud C; Desjeux A; Garcia S; Desplat-Jégo S
PLoS One; 2013; 8(11):e80433. PubMed ID: 24303014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
